Why Novavax Stock Is Losing Ground
May 03, 2021 at 18:11 PM EDT
Shares of coronavirus vaccine developer Novavax, Inc. (NVAX) were moving sharply to the downside on above-average volume Monday. Novavax shares lost 17.65% Monday, closing at $195.12.
